CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Celyad Oncology Company Snapshot
Celyad Oncology Formerly known as Cely ad SA. Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure, allows the differentiation of a patient's own cells into cardiopoeitic cells which grow into new heart cells and repair heart muscle. C-Cure consists of autologous adult stem cells guided in vitro to the cardiac lineage before implantation in the failing heart. Furthermore, the Company is involved in the field of immuno-oncology, through its subsidiary, OnCyte.

Sales Analysis. Sales fell dramatically in 2019: During the year ended December of 2019, sales at Celyad Oncology were 6,000.00 Euro (US$6.74 thousand). This is a sharp decrease of 99.8% versus 2018, when the company's sales were 3.12 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Celyad Oncology
  Stock Performance Chart for Celyad Oncology
 
  Stock Data: Recent Stock Performance:
  Current Price (6/26/2020): 9.94
(Figures in Euros )
1 Week -3.1%   13 Weeks -1.6%  
4 Weeks 48.6%   52 Weeks -2.5%  
 
Celyad Oncology Key Data:
  Ticker: CYAD Country: Belgium
  Exchanges: BRU Major Industry: Health Care Equipment & Services
    Sub Industry: Health & Allied Services
  2019 Sales 6,000
(Year Ending Jan 2020).
Employees: 107
  Currency: Euros Market Cap: 138,586,899
  Fiscal Yr Ends: December Shares Outstanding: 13,942,344
  Share Type: Actions Ordinaires Closely Held Shares: 2,295,701
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.